Alison Gill

Alison Gill is a Business Analyst at McKinsey & Company since February 2024, having previously served as an Operations Associate at Prevail Fund from January 2023 to February 2024. Alison's experience includes consulting on a major merger in the insurance industry and supporting strategic planning at both McKinsey & Company and Back Bay Life Science Advisors, where work involved evaluating clinical and commercial strategies in oncology. Additional roles include internships focused on COVID-19 initiatives at P33 Chicago, clinical research at UChicago Medicine, and laboratory research at Geneoscopy. Alison holds a Bachelor of Science in Molecular Engineering from the University of Chicago and has further education from The University of Chicago Booth School of Business.